Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013963
Filing Date
2023-08-08
Accepted
2023-08-08 16:32:54
Documents
70
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ampe-20230630x10q.htm   iXBRL 10-Q 1371748
2 EX-31.1 ampe-20230630xex31d1.htm EX-31.1 16182
3 EX-31.2 ampe-20230630xex31d2.htm EX-31.2 16157
4 EX-32.1 ampe-20230630xex32d1.htm EX-32.1 9404
5 GRAPHIC ampe-20230630x10q002.jpg GRAPHIC 3040
  Complete submission text file 0001558370-23-013963.txt   6424624

Data Files

Seq Description Document Type Size
6 EX-101.SCH ampe-20230630.xsd EX-101.SCH 47130
7 EX-101.CAL ampe-20230630_cal.xml EX-101.CAL 39834
8 EX-101.DEF ampe-20230630_def.xml EX-101.DEF 176644
9 EX-101.LAB ampe-20230630_lab.xml EX-101.LAB 324547
10 EX-101.PRE ampe-20230630_pre.xml EX-101.PRE 301818
64 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20230630x10q_htm.xml XML 1297478
Mailing Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112
Business Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 231151973
SIC: 2834 Pharmaceutical Preparations